Biotech Strategy … Going Forward

June 6, 2022 By in Biotech, Dr. Elder, LABD, LABD-22-03, Prechter, SPBIO, Wyckoff 2 Comments

SPBIO, Correction Complete

This morning’s action in biotech SPBIO, indicates we’re done with the upward corrective move.

The prior short position LABD-22-02, was reduced throughout the downward push over the past week and then exited completely in this morning’s pre-market session.

Within minutes after the open, as LABD pushed lower (SPBIO higher), it became obvious, a significant reversal was at hand.

It took LABD, just a little over two minutes to clear out stops and then begin an upside reversal.

Amateur vs. Professional

Dr. Alexander Elder covers the amateur/professional difference in his book Come Into My Trading Room.

That is, if an amateur gets stopped out or exits with a loss, they never come back.

Even if the trade reverses to go their direction, they refuse to re-position … having been ‘spanked’ by the market.

Breaking free of the (engineering) perfectionist mindset, is just one challenge during the journey to professional.

It must be overcome to achieve sucess in the markets.

Re-Positioned, Short

All of the above to say, the short in biotech has been re-established: LABD-22-03 (not advice, not a recommendation).

The difference at this point is, there’s a high level of expectation on what’s likely to happen next.

As Wyckoff put it a century ago, the reversal and re-position, enables us to be ‘in tune’ with price action.

Biotech SPBIO, Weekly

We’re going to invert the chart and mark it up.

First off, we can see the rule of alternation at work.

Next, we have at least two potential trading channels.

This one …

And this one …

We’ll let price action itself define which one (or none) is in-effect.

When we get a corrective move that resolves itself, at times, it creates a pivot point with a different rate of advance or decline.

That means, there’s more than a good possibility, the second (more aggressive) channel, is now dominant.

Summary

As this trade progresses, we’ll cover potential areas where the existing position can be increased with as low risk as possible.

As this juncture, LABD is trading in the area of 55.25.

The early (pre-market) loss has been more than recovered and we’re now well in the green for the day.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Grinds To A Halt

June 4, 2022 By in $SPSIBI, Biotech, LABD-22-02, Neil McCoy-Ward, S&P, S&P 500, SPBIO 3 Comments

‘Two Weeks, To Flatten The Curve’

On a weekly closing basis (as we’ll see below), it’s obvious.

Upward (net) progress in biotech SPBIO, has come to a standstill.

While the media continues to foment the lie that somehow interest rates have reached their limit, or ‘Da Fed’, is going to do this or that, behind the scenes the plan … set out years ago, continues to unfold.

Before we get to the charts, let’s not forget what’s happening ‘out there‘. The number of idiots seems to be increasing without bound.

As Goethe said way back in 1826, ‘There is nothing more frightful than ignorance in action’. He was being polite with the ‘ignorance’ part.

Now, on to the charts.

The un-marked, chart of biotech SPBIO, is below.

The second chart zooms-in, showing the percentage changes on a closing basis.

Biotech SPBIO, Weekly

Zoom in, showing net progress.

One would think, since biotech has dropped so significantly, there’s no more (downside) left.

Certainly, anything can happen.

However, the premise is, the overall collapse is still in the early stages.

We have not (yet) had a 50% – 90%, drop in the S&P.

In addition, pension funds are likely to go broke.

So all those $250,000/year ‘retired’ lifeguards that J.B. has spoken about? Well, how do you leverage that ‘skill’ to another industry?

SPBIO, Inverted

Next up, the inverted chart of SPBIO, to mimic the action seen in leveraged inverse, LABD.

Then after that, is the same chart marked with a potential forecast of where price action may be heading (not advice, not a recommendation).

Now, the markup showing potential action should biotech continue its decline.

Zooming in on the last few weeks of action.

The fact price action has bounced from this area of the chart, tells us the trading range is valid; the blue line is being recognized by the market.

Now as shown, we’ve come to a halt.

So, what happens next?

Positioning

As SPBIO ground its way higher (LABD lower) over the past week, the short position, LABD-22-02, was reduced further but not eliminated (not advice, not a recommendation).

Since there’s no more net progress upward and we’re still in an overall downtrend, expectations are for biotech to either stall, or reverse, continuing its trend lower.

As stated previously in this post, the market’s prior congestion was ‘complex’.

So, we’re expecting ‘simple’ this time around; all of which lends support to more downside.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … The Case For Collapse

June 1, 2022 By in Appalachia's Homestead, Biotech, CVNA, I Allegedly, Jerimiah Babe, LABD, LABD-22-02, SPBIO

Down 90%, Before October ?

If all the “Ifs”, come true.

First off, biotech (SPBIO), may already be in a collapse.

Of all the major sectors, it’s leading the way lower; down -61%, from all-time highs, set in February of 2021.

With SPBIO, lower by that much, are there still downside opportunities?

Only you can be the final judge of that.

However, for my firm, I’m not waiting around to see what happens next; we’re already short (not advice, not a recommendation)

SPBIO, Summary

As we’ll show below, SPBIO’s maintaining price action in a downside channel, declining at approximately -97.8%, on an annualized basis.

If that channel is held for the next three months (a big if) and if there’s no ban on short sales (as happened last time in 2008), and if the vehicle itself (LABD) remains viable, we can look for a -90%, decline from all-time highs, by October at the latest.

Why -90% ?

We’re using our chief, cook, and oh so, ‘disruptive’ bottle-washer, Carvana (CVNA) as the example.

The last report on Carvana, highlighted the possibility that it’s ripe for implosion.

The very next session, that implosion started in earnest.

Currently trading at 26.53, CVNA is down -92.96%, from all-time highs.

So, -90% (or more), for biotech seems reasonable 🙂

Throwing in a couple of anecdotal comments from J.B., Dan, and Patera, and voila! ‘This sucker could go down.’

Moving on to the main topic.

Biotech SPBIO, Weekly

Here’s where we are with the un-marked chart.

We’re going to compress the chart and put in the channel lines. The lower horizontal line marks a decline of -90%, from all-time highs.

If price action maintains the right-side trend line, a 90% decline, targets right around October this year.

Summary

This analysis could be blown away, rendered invalid, at the very next session.

That’s the way of the markets.

As sated, current positioning is to be short the sector via LABD, with trade LABD-22-02 (not advice, not a recommendation).

As a result of today’s action thus far, we’ve got a hard stop for LABD, currently @ 55.73.

Even as this post is being created, SPBIO action continues to grind down; threatening to post a new weekly low.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Stall & Reverse

May 31, 2022 By in $SPSIBI, Biotech, Jerimiah Babe, LABD, LABD-22-02, SPBIO

Heading Off The Cliff ?

We’re about to find out.

The last update presented that whatever happens with biotech (SPBIO), it’s likely to be decided quickly.

That conclusion was based on the ‘rule of alternation’ and the fact, the whole short squeeze event from last week, did not result in a new weekly high.

That, Was Then

What we have now so far in today’s session, is an attempt to move higher by SPBIO, which appears to have stalled and now, looking to reverse.

The reversal part won’t be confirmed unless, and until a new daily low is posted.

For today, posting a new low is somewhat of a tall order because of Friday’s wide trading range … but we’ll see.

Instead of going to the actual index, SPBIO, we’ll look at the 3X leveraged inverse fund LABD

SPBIO, 3X, Leveraged Inverse, LABD

Note:

The chart below, is a 3-Day chart with Friday, completing the last ‘third’ day.

As price action has moved lower, energy behind that move is weakening; seen in the thrust divergence

Why a 3-Day Chart?

When’s the last time you saw a 3-Day, 2-Day, or 6-Day, or any other non-conventional chart in anyone’s analysis?

Anybody? … Bueller? Bueller?

It’s not different, just to be different.

Shown below, we have the same 3-Day LABD, compressed and marked up with a trading channel.

At this juncture, the 3-Day shows the nuances more clearly.

If this trading channel is in-effect, that is, if it’s active, potential exit points for an LABD position at this point in time, would be 105, or 240 (not advice, not a recommendation).

For LABD, to get anywhere close to those points, especially the second (240-level), biotech would need to collapse.

Summary

There’s plenty of chaos to go around. We have those who are still arguing whether or not ‘it’s the bottom’.

Such arguments are potentially (and likely) from those completely unprepared.

As Jerimiah Babe said in one of his latest videos, ‘something’s going to break’.

When or if that break happens, it won’t be to the upside.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

S&P Rally to Continue ?

May 30, 2022 By in Economic Ninja, I Allegedly, S&P, S&P 500, Spring-to-Up-Thrust, SPY, Wyckoff

Dan … We’ve Bottomed Out !!!

‘Hey Dan, the worst is behind us.’

That’s going to age just as well as our picture at left.

Toilet paper across my face, makes me feel so much more safe.

Within the first ten seconds in the link above, Dan from i-Allegedly gets into it.

He still, at this late stage, has people contacting him to say we’re past the bottom.

He summarizes those comments by saying, ‘We’re far from the bottom of anything.’

Then, as if on cue, ‘Economic Ninja‘ comes online to let us know, another 200,000 egg-laying chickens have just been destroyed in a ‘mysterious fire’ … imagine that.

Almost becoming background noise to all this, the S&P 500, in a sharp rally on Friday that looks like it won’t stop.

S&P 500, Summary

Friday’s action took the S&P back to test resistance on waning volume while at the same time, posting a Wyckoff spring to up-thrust.

That’s it in a nutshell.

Daily SPY, Close

With markup notes

Getting closer-in on the candle chart.

Futures Market

As of this post (3:31 p.m., EST) the futures are higher by a tad at +0.52%. The question is, will that carry-through into the Tuesday open?

Of course, that’s not known. What we do know however, is that price is at established resistance and in up-thrust (potential reversal) condition.

Even if the ultimate direction for the market is higher, normal behavior would suggest a pull-back to gather more fuel for such an attempt.

Otherwise, we’re at the danger point; conditions have been set for downside reversal.

Stay Tuned

Update 6:47 p.m. EST:

S&P futures dropping … now up only +0.17%

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Economic Free-Fall

May 29, 2022 By in $SPSIBI, Appalachia's Homestead, BIS, DRV, DRV-22-03, I Allegedly, IBB, IYR, Jerimiah Babe, LABD-22-02, Red Hurricane, SPBIO, Wyckoff, ZeroHedge 2 Comments

Anecdotal Data, Says Implosion

As we speak, economic activity is shutting down … fast.

Amazon shipments cancelled, gas stations going dry, banks halt lending, real estate sales collapse.

Meanwhile, the market’s in a short-squeeze.

What happens next?

We’ll discuss real estate and biotech farther down but first the data sources.

Dan from i-Allegedly reports here, he still has a couple of rubes (my word) that think the market just bottomed out.

Good luck with that.

As we’ll show below, the real estate bear market (IYR) rebound, was identified ahead of time.

Next, we have Red Hurricane describing one semi-trailer load after another being cancelled. He hauls for Amazon.

Shipping activity’s contracting, seemingly, by the minute.

Lastly, this link where the D-word, ‘Depression’ is used within the first one-minute, twenty seconds.

Bottom-out in the stock market? Probably not.

So, let’s take a look at real estate IYR, and see where it might go next.

Real Estate IYR, Weekly Chart

The last update (link, here) showed potential to rise into a test of resistance. That’s exactly what happened.

Back then:

And now:

With zoom

Obviously, the upward test happened much quicker than anticipated … but it was anticipated … no surprise.

Real estate got itself into Wyckoff spring position; so, a rebound (test) is normal market behavior … short-squeeze or not.

If it was a squeeze and if it’s over, we can expect an immediate drop in price action. We’ll analyze that as it plays-out in the coming week.

Now, on to biotech, SPBIO

Biotech SPBIO ($SPSIBI), Weekly

Some housekeeping first.

Obviously last week, with being short, more downside action was anticipated resulting in upside for LABD.

On Friday, that did not happen. Biotech was part of the squeeze as well.

The short position via LABD, identified as LABD-22-02, was reduced but not exited completely (not advice, not a recommendation).

At present this is where we are.

First, we’ll start by inverting the chart to mimic the action of 3X inverse, LABD.

Next, we’ll zoom-in and highlight the ‘squeeze’.

Doesn’t look like much when viewed that way does, it?

Next, we’re going to zoom-in, on the zoom

In spite of all the squeeze chaos on Friday, price action could not post a new weekly low (high on the non-inverted).

We’ll see this Tuesday, if that’s important or not.

This post is getting long but let’s end with the rule of alternation. The same chart is marked up below.

If this rule is still in-effect, we’re at a juncture where one can expect a ‘simple’ alternation.

We’ve already had complex action on the prior congestion; so, we can expect current action to be simple in character.

That means, price action’s not likely to stick around at these levels whether it’s going up or down.

Based on the above analysis, the expectation for Tuesday’s open is a gap lower for SPBIO and higher for LABD.

If that does not happen, something else is at work … we’ll report on that as necessary.

Summary

Has the market bottomed out? Not likely.

Those who are at this late stage, still arguing with Jerimiah Babe and Dan (and Patera), that the market’s rebounding, everything’s fine, are in a state of delusion.

The mindless herd following spending with ever newer cars, moving up to the McMansion, opulent vacations, posting it all on Facebook is most decidedly, gone.

It’s finished. It’s Done.

The problem is, as J.B. notes above (time stamp 7:15 and 8:30), those still living that life don’t seem to know it’s over.

For the leaders, the tiny minority and those reading this post, who are, or who have been preparing for years, it means potential huge (life changing) opportunities.

That is, as long as the markets, the banks and other infrastructure stay open; not guaranteed in any way.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Investors’ Buy Dip Over & Over

May 26, 2022 By in Biotech, BIS, BIS-22-01, I Allegedly, LABD, LABD-22-02, SPBIO, The Maverick of Wall Street, Wyckoff 1 Comment

“Fuel” For The Downside

Once this next level gives way, carnage will (likely) reach all-time records.

Over a centry ago, Wyckoff said in his writings, it’s those on the wrong side of the bull trade, who provide the fuel on the way down.

As reported by Reuters, that downside fuel appears to be building on a massive scale.

The Fed This … The Fed That

What a colossal waste of time … that is, trying to figure out what The Fed is, or is not, going to do.

As The Maverick reports in this update, The Fed has a higher authority. It should be no surprise to any of us at this point … they’re ‘just following orders’.

Mirroring that sentiment is Dan from i-Allegedly, saying ‘This is not the bottom‘.

Part of the reason there’s so much focus on earnings, financials and The Fed, is that it’s a whole lot easier to do that, than actually getting down to work and learning price action.

That my friends, as Wyckoff said in his text Studies In Tape Reading, ‘takes many years and many losses’.

So, let’s take a look at what that ‘tape’ is telling us concerning the biotech market.

Biotech Inverse BIS and LABD

The prior analysis on IBB, is still valid.

However as was done with real estate, changing from 2X inverse to 3X inverse, the same has happened with biotech; from BIS, to LABD.

Since the overall bearish assessment has not changed, this morning’s upward move in the markets was used to re-position to a higher (inverse) leverage vehicle … LABD (not advice, not a recommendation).

The hourly charts below show the exit of BIS and the entry of LABD.

Biotech 2X Inverse, BIS

Biotech 3X Inverse, LABD

As this post is being written 12:55 p.m., EST, price action’s at the danger point.

We’re at the extreme; the risk is least but price can go either way.

Summary

Watching that action in real time, it looks like LABD wants to go higher; currently trading at 57.20-ish.

If LABD is higher, that means SPBIO, is moving lower.

Unless price action of biotech (IBB, SPBIO) and the overall markets signal a change of behavior … the bear move is still in play.

If we get a significant break lower, ‘retail’ that’s not positioned properly, will provide the majority of downward thrust energy.

It’s no different than it was in Wyckoff’s time, over a century ago.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … The Breakdown

May 24, 2022 By in Biotech, BIS, BIS-22-01, David Weis, IBB, LABD, SPBIO 1 Comment

Wedge Break Has Been Tested

It’s been a while since we’ve talked about the chief cook and bottle washer in this whole financial collapse scenario.

However, biotech has not been forgotten.

There are two indices (ETFs) being tracked: IBB and SPBIO.

Both entered bear market territory long ago. SPBIO topped out, way back in February 2021; IBB topped later, in August the same year.

Leveraged inverse funds are LABD, and BIS, respectively. LABD is 3X inverse with BIS a 2X inverse.

The Long Term

One thing unique to David Wies, was to look at the long term: Monthly, Quarterly and Yearly charts.

Doing so, puts one in a strategic mindset … not easily swayed by the latest prattle from media sources.

If we look at biotech, IBB, on a quarterly basis we have the following chart.

Biotech IBB, Quarterly

The mark-up of this chart is where it gets interesting.

A terminating wedge that’s been over seven years in the making has just broken to the downside.

Not only that, when we get closer-in (on the weekly), we can see the wedge break has been tested and now today, appears to be reversing to the downside (shown on daily).

Biotech IBB, Weekly

With zoom

The daily shows a Fibonacci retrace to 38%; then today, a downside reversal.

You can see where this is going.

Based on the above analysis a short position in IBB, has been opened via BIS (not advice, not a recommendation).

The trade is BIS-22-01, with an (initial) entry @ 28.5173

Summary

The news on specific biotech companies is already out if one knows where to look.

Stated time and again on this site, we’re just in the beginning stages of the repercussions.

It even looks like they’ve moved on from the initial scam and are cooking up a new one.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Could Real Estate Rally?

May 23, 2022 By in DRV, DRV-22-02, IYR, ZeroHedge 1 Comment

How Is That Possible?

It’s possible, because price action is always the final arbiter.

Before the rest of the report, some housekeeping.

Real Estate IYR, has broken the down trend lines previously discussed.

A discretionary (not stop related) exit was performed on all positions at approximately DRV 46.45.

Trade DRV-22-02, is officially closed.

If the market turns around and looks like IYR is about to resume its downtrend, the DRV position could be re-established (not advice, not a recommendation).

As it stands, profit on the entire DRV-22-02, was in the vicinity of +19.2%.

That’s not too bad, considering the rest of the population is losing their shirts as reported here.

There were 25 DRV, transactions during the trade.

Where to Now?

Real estate can resume the downtrend, or it can test the underside of support, now resistance (shown below).

Under ‘normal’ market conditions, a test is typical behavior.

However, we’re in a financial collapse so anything is possible.

Real Estate IYR, Weekly

The chart above paints a familiar picture.

The overall trend is down. However, that does not mean price can’t go higher.

In fact, as we all know, the sharpest rallies occur in the middle of bear markets.

Whether we get one now, is unknown. Typical market behavior is to come back to the resistance area (black axis line) for a test.

Summary

From personal standpoint, I’ll take the near 20% gain (not advice, not a recommendation) and stand on the sidelines for a more definitive set-up.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Weekly, Wrap-Up

May 22, 2022 By in CARES, CVNA, Doug Casey, IYR, PLD, Prechter, Usual Suspects, Weekly Wrap-Up 1 Comment

The Usual Suspects

No. 1

Carvana Fires 2,500 Employees

We didn’t see that one coming. Or, did we?

Just a quick review of this report posted over six-months ago:

“If your biggest claim to fame is that you ‘invented’ a vending machine … you’ve got real problems.”

“As the economy (if you can call it that) falls off the cliff, one of these two (CMX, CVNA), is not likely to survive.”

Well, looks like we have the answer on that one.

From the date of the report above to last Friday’s close, CVNA, is down -87.8%.

Measured from all-time highs, CVNA, is down -91.1%.

As CVNA, swirls down the drain of ‘disruption’, looks like it was only a blip in the land of ‘status quo’.

No. 2

The ProLogis ‘Connection’

Is this a re-print of a prior report?

No, the update below, is essentially a confirmation of the analysis in that (above) report.

Turns out that Amazon (link here) is in negotiations with chief cook and warehouse bottle-washer, ProLogis (here) about terminating massive amounts of lease space.

The entire affair, is an irrefutable confirmation of the Wyckoff analysis method.

That is, ‘the market itself defines it’s next likely course’.

Those on the inside always know something; that ‘something’ (i.e., their actions) shows up on the tape.

After the initial ‘ProLogis Connection’, a follow-up was posted that identified the largest down-thrust energy in ProLogis history.

From that report was this quote:

“We’re using PLD, as the proxy for the real estate (IYR) sector as it’s the largest cap equity.”

“That’s true for now … but maybe not for long.”

How quickly things change.

ProLogis is now the number two in the IYR market cap and very close to being third.

No. 3

Wealth Confiscation Coming Soon

The first two bullets perceived events before they happened, so let’s make it three-in-a-row.

This one’s pretty much a no-brainer.

During the last meltdown in 2007 – 2009, IRA retirement accounts came within a hairs-width of being confiscated.

This time around, could be for sure.

The following’s a section of a report written years ago.

It’s even more relevant now.

Begin Report

4/7/19

Government To Confiscate IRAs?  It’s Easy

There has been enough time for the American working (and saving) public to take the lessons of the 2007- 2009 meltdown and act accordingly.

One of those lessons would have been to realize, just how close they came to having their IRAs confiscated.

Personally, I’m surprised that any of the following links below are still active.  Well, who’s looking at this stuff anyway?  Certainly, not the general public:

Dems Target

Fact Check

Congress considering

Government to Confiscate (no longer active)

Confiscation of Private Retirement

Even in the Wall St. Journal:  Targeting your 401K

After reading several of these reports in 2009 and later, it did not take long for me to set the plan in motion to cash out … completely.  I took the 10% penalty, while it’s still 10% and liquidated my accounts.

The rest of the population?  Not so much.

I think it was Prechter who laid out just how easy it is for the government to seize IRA accounts.  It’s basically a two step process.

Step 1.  The market drops 50% to 70%.  Remember, the drop from 2007 to the bottom in 2009 was 58%.

Step 2.  Declare a state of emergency (executive order) for the working population and move in to “save” the IRA accounts from more devastation.  The result would involve a stiff withdrawal penalty (say 50%) and to “protect” the accounts from further losses, IRAs can only invest in U.S. Treasuries or Bonds.

It’s that easy. 

As stated previously, wealth does not necessarily mean gold and silver.  That too can (and has been in the past) be confiscated.

In fact, I and my firm are already operating as if the next crisis is in full swing and asset confiscation is the norm.  That way, we don’t have to come up to speed quickly in what may be an extreme stress situation. 

End Report

One could propose that (IRA) legislation is already written.

Just like the CARES Act was already written and submitted to committee in January of 2019, nine months before there was any kind of outbreak.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279